COFCO Biotechnology Co., Ltd.
000930.SZ · SHZ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | CN¥11,046 | CN¥10,375 | CN¥10,059 | CN¥10,325 |
| - Cash | CN¥2,518 | CN¥2,388 | CN¥1,797 | CN¥1,909 |
| + Debt | CN¥4,176 | CN¥4,430 | CN¥4,974 | CN¥4,342 |
| Enterprise Value | CN¥12,704 | CN¥12,417 | CN¥13,235 | CN¥12,758 |
| Revenue | CN¥4,449 | CN¥4,427 | CN¥4,385 | CN¥4,929 |
| % Growth | 0.5% | 0.9% | -11% | – |
| Gross Profit | CN¥318 | CN¥300 | CN¥354 | CN¥20 |
| % Margin | 7.1% | 6.8% | 8.1% | 0.4% |
| EBITDA | CN¥11 | CN¥165 | CN¥230 | -CN¥168 |
| % Margin | 0.3% | 3.7% | 5.2% | -3.4% |
| Net Income | -CN¥28 | CN¥67 | CN¥41 | CN¥16 |
| % Margin | -0.6% | 1.5% | 0.9% | 0.3% |
| EPS Diluted | -0.015 | 0.036 | 0.022 | 0.008 |
| % Growth | -142.1% | 64.7% | 159.5% | – |
| Operating Cash Flow | CN¥422 | CN¥1,048 | -CN¥256 | CN¥0 |
| Capital Expenditures | -CN¥203 | -CN¥126 | -CN¥124 | -CN¥171 |
| Free Cash Flow | CN¥219 | CN¥922 | -CN¥380 | -CN¥115 |